OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

During the Trading Day
2.03 -0.05 / -2.40%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.00 -0.03 / -1.48%
Volume: 1.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues13.6M5.5M20.1M29.9M
Operating ExpensesGross Income13.6M5.4M----
Total Operating Expenses24.3M27.8M47.7M65.2M
Non-Operating ExpensesOperating Income-10.7M-22.3M-27.6M-35.3M
Extraordinary Credit96.0K7.4M6.3M3.2M
Extraordinary Charge-5.1M0.000.000.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.6M-14.7M-21.1M-31.8M
Income Taxes-3.0M0.000.000.00
Net Income-12.6M-14.7M-21.1M-31.8M
Shares To Calculate EPSShares To Calculate EPS7.0M9.7M13.5M14.7M
Shares To Calculate EPS Diluted7.0M9.7M13.5M14.7M
Earnings Per ShareEPS-$1.79-$1.51-$1.56-$2.17
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.